FIND DOCTORS
-
Name: Chang,Jianhua
Department: MEDICAL ONCOLOGY
Title:ProfessorEducation & Professional Experience 2005-Present Department of Medical Oncology of Fudan University Cancer Hospital Associate Professor
2002-2005 Department of Medical Oncology of Sun Yat-sen Cancer Center Post doctor
1999-2002 XiangYa Hospital of Central-South University Ph.D of Medical Oncology
1997-1999 Second Affiliated Hospital of Hunan Medical University Master of Medical Oncology
1988-1997 Department of Hematology/Oncology of Affiliated Hospital of Guilin Medical College Resident physician and attending doctor
1983-1988 Guangxi Medical University Bachelor of Medicine
Specialty Lung cancer , Esphageal cancer, Research 1.OPEN-LABEL STUDY OF BEVACIZUMB（AVASTIN)IN COMBINATION WITH PLATINUM-CONTAINING CHEMOTHERAPY AS FITST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR RECURRENT NON-SQUAMOUS NON-SMALL CELL LUNG CANCER （SAIL STUDY）
2. A RANDOMISED PHASE Ⅱ STUDY OF ORAL VINORELBINE IN COMBINATION WITH CISPLATIN VERSUS Ⅳ VINORELBINE IN COMBINATION WITH CISPLATIN IN UNRESECTABLE LOCALISED OR METASTATIC NON-SMALL-CELL LUNG CARCINOMA.
3. A PHASEⅢ,INTERNATIONGNAL,RANDOMISED,DOUBLE-BLIND,PARALLEL-GROUP,MULTI-CENTER STUDY TO ASSESS THE EFFICACY OF ZD6474(ZACTIMA) PLUS BEST SUPPORITIVE CARE VERSUS PLASEBO PLUS BEST SUPPORTIVE CARE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC(STAGE IIIB-Ⅳ)NON-SMALL CELL LUNG CANCER(NSCLC)AFTER PRIOR THERAPY WITH AN EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR(EGFR TKI)
4. Phase III randomized clinical trial of intertumoral of E1B gene deleted adenovirus (H101) in treating squmous cell cancer of head and neck or esophagus.Publication 1. ZHAO XY, HONG XN, CAO JN, LEAW SJ, GUO Y, LI ZT, CHANG JH CLINICAL FEATURES AND TREATMENT OUTCOMES OF 14 CASES OF PRIMARY OVARIAN ON-HODGKIN'S LYMPHOMA: A SINGLE-CENTER EXPERIENCE. MED ONCOL. 2010 MAY 28. [EPUB AHEAD OF PRINT]（CORRESPONDENT AUTHOR）
2. JIANHUA CHANG, XIAOYING ZHAO, XIANGHUA WU, YE GUO, HAIYI GUO, JUNNIN CAO, YONG GUO, DELUN LOU, DECHAO YU, JIN LI A PHASE I STUDY OF KH901, A CONDITIONALLY REPLICATING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR: ARMED ONCOLYTIC ADENOVIRUS FOR THE TREATMENT OF HEAD AND NECK CANCERS. CANCER BIOL THER. 2009 APR;8(8):676-82.
3. CHANG Jian hua,SHI Yan xia,LI Jin.et al.DC loaded with CPP-Id increase the efficiency of CTL proliferation and enhance its cytotoxicity in vitro. CHINA ONCOLOGY, 2006,16(12):1007-1010
4. CHANG Jian hua,SHI Yan xia, ZHANG Xiao shi. et al. Impact of CPP-Id on Expression of Co-stimulating Molecules. Chinese Journal of Cancer.2005,24(12):1484-1488
5. CHANG Jian hua,Ma Yue, ZHANG Guang-sen. Frequency of gene G20210A varient in the 3’-untranslated region in Zhuang ethnic Chinese. Chin J Med Genet, 2005, 22(6): 341-343Out-patient Schedule Moonday Afternoon
